View Older Stories View More Recent Stories

Sep 16, 2015 10:32AM Notable Analyst Rating Changes 9/16: (CST) (YNDX) (ORCL) Upgraded; (HST) (FOLD) (MRK) Downgraded
Sep 16, 2015 08:06AM Chardan Capital Markets Downgrades Amicus Therapeutics (FOLD) to Neutral
Sep 15, 2015 04:13PM La Jolla Pharmaceutical (LJPC) Closes 2.9M Common Stock Offering
Sep 15, 2015 04:11PM La Jolla Pharmaceutical Company Closes Offering of Common Stock
Sep 14, 2015 08:28AM Chardan Capital Positive on Globalstar (GSAT) Following FCC Ex Parte Filing on TLPS Demo
Sep 10, 2015 10:26AM Chardan Capital Markets, LLC. Announces Hiring of Michael E. Marrus to The Special Equities Group
Sep 10, 2015 08:02AM La Jolla Pharmaceutical (LJPC) Prices 2.55M Common Stock Offering at $38/Share
Sep 10, 2015 08:00AM La Jolla Pharmaceutical Company Announces Pricing of Underwritten Offering of Common Stock
Sep 8, 2015 02:47PM Notable 52-Week Highs and Lows 9/8: (JBLU) (NAVB) (LJPC) High; (GPRO) (YGE) (VNCE) Low
Sep 8, 2015 01:00PM Unusual 11 Mid-Day Movers 9/8: (CAPN) (TE) (LJPC) Higher; (ACI) (YGE) (NOR) Lower
Sep 8, 2015 11:56AM REGENXBIO (RGNX) Sees IPO Price of $17 - $19/Share
Sep 8, 2015 07:49AM Chardan Capital Markets Starts Nanosphere (NSPH) at Buy
Sep 8, 2015 06:25AM Chardan Capital Boosts PT on La Jolla Pharma (LJPC) to $80 Following CEO Meeting
Sep 3, 2015 08:17AM Amicus (FOLD) Worth Up to $50/Sh in a Takeover, Chardan Says; Scioderm Deal Terms Suggest Future Sale
Aug 31, 2015 10:46AM Notable Analyst Rating Changes 8/31: (QLGC) (TWTR) (MS) Upgraded; (RGS) (UTX) (SCCO) Downgraded
Aug 31, 2015 08:12AM Chardan Trims PT on Esperion (ESPR) to $36 as Negatives Continue Increasing
Aug 31, 2015 07:57AM Chardan Capital Markets Downgrades Regeneron Pharma (REGN) to Neutral
Aug 27, 2015 12:12PM Streetinsider.com's Hot Lunchtime Reads 8/27: (TSLA) (RJET) (QURE) (WSM)
Aug 27, 2015 12:02PM Chardan Capital Trims PT on uniQure (QURE) to $35; Notes Uncertainty of Glybera in the U.S.
Aug 18, 2015 08:24AM Chardan Capital Markets Reiterates Buy on CEVA, Inc. (CEVA) Ahead of Galaxy Note 5 and S6 Edge+ Launch
Aug 18, 2015 08:17AM Chardan Capital Affirms Esperion (ESPR) at 'Sell'; Bear Case Confirmed, CVOT Needed for P2 Indications
Aug 18, 2015 08:00AM Chardan Capital Markets, LLC Expands Global Platform With The Appointment Of George Nikitiadis As Managing Director And Head Of The International Portfolio Team In New York
Aug 17, 2015 02:00PM REGENXBIO (RGNX) Files for $100M Common Stock IPO
Aug 17, 2015 09:29AM Pre-Open Stock Movers 08/17: (AVEO) (ZU) (KITE) (TSLA) Higher; (ONTX) (MU) (EL) Lower (more...)
Aug 17, 2015 08:57AM UPDATE: Chardan Upgrades Avalanche Biotechnologies (AAVL) to Buy
Aug 14, 2015 08:55AM YOU On Demand (YOD) has Another Impressive Quarter; Chardan Capital Affirms 'Buy' Rating
Aug 12, 2015 06:00AM Unique Fabricating, Inc. Reports Second Quarter Revenues of $35.7 Million; Diluted Earnings Per Share of $0.24
Aug 7, 2015 08:30AM Chardan Capital Trims PT on Esperion (ESPR) Following Q2 Results, TAK-475 Failure Concerning for ETC-1002
Aug 5, 2015 01:30PM Eyegate Pharmaceuticals Announces Closing of Public Offering of Common Stock and Warrants
Aug 5, 2015 10:15AM RADA Announces Closing of Public Offering of Its Ordinary Shares
Aug 5, 2015 08:14AM Chardan Capital Sees Himax (HIMX) Missing Q3 Revenue Estimates; Offers Update
Aug 4, 2015 09:00AM Chardan Releases Industry Report Covering PharmaCyte Biotech
Aug 3, 2015 02:46PM Chardan Capital Affirms Axovant Sciences (AXON) at 'Sell'; Sees as Mispriced Following vTv Therapeutics (VTVT) IPO
Aug 3, 2015 08:00AM Chardan Capital Markets, LLC Expands Equity Division With Appointment Of Jeff Sklar, Managing Director and Head Of Institutional Sales
Aug 3, 2015 07:48AM Chardan Capital Markets Starts MassRoots (MSRT) at Buy; Largest Social Network for Cannabis Community
Jul 31, 2015 10:44AM Chardan Capital Boosts PT on Esperion (ESPR) to $45; New Disclosure Does Not Reveal Higher Rate of SAEs for ETC-1002
Jul 31, 2015 09:17AM EyeGate (EYEG) Prices $10M Offering of Common Stock and Warrants
Jul 31, 2015 07:14AM RADA Electronic Industries (RADA) 6.9M Stock Offering Prices at $1.23/Share
Jul 30, 2015 07:26PM RADA Announces Pricing Of Public Offering Of Its Ordinary Shares
Jul 30, 2015 06:08PM EyeGate Pharmaceuticals Announces Pricing of $10,000,000 Public Offering of Common Stock and Warrants
Jul 30, 2015 06:08PM EyeGate Pharmaceuticals Announces Pricing of $10,000,000 Public Offering of Common Stock and Warrants
Jul 29, 2015 04:15PM Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors
Jul 27, 2015 08:47AM Chardan Capital Sees Axovant's (AXON) RVT-101 Only Costing $5M Upfront; 'Sell' Rating Affirmed
Jul 27, 2015 08:31AM Esperion Therapeutics (ESPR) PT Cut to $40 at Chardan Capital Markets
Jul 27, 2015 08:23AM VistaGen Therapeutics (VSTA) Highlighted at Chardan Capital After Allergan Acquires Comp Naurex
Jul 24, 2015 08:45AM IDI, Inc. Announces $10 Million Registered Direct Offering
Jul 23, 2015 09:40AM Chardan Capital Trims PT on Axovant (AXON) to $9.50; News is Good, but 24+ Late-Stage Alzheimer's Drugs in Development
Jul 22, 2015 08:19AM Chardan Capital Markets Starts Applied Genetic Technologies Corp. (AGTC) at Buy
Jul 15, 2015 10:18AM Notable Analyst Rating Changes 7/15: (GES) (CSX) (LNKD) Upgraded; (LLY) (LPLA) (CINF) Downgraded
Jul 15, 2015 08:30AM OncoCyte Announces Appointment of Andy Arno to Board of Directors
View More Recent Stories View Older Stories